Form preview

Get the free Form FDA 1571 - Investigational New Drug Application

Get Form
We are not affiliated with any brand or entity on this form
Illustration
Fill out
Complete the form online in a simple drag-and-drop editor.
Illustration
eSign
Add your legally binding signature or send the form for signing.
Illustration
Share
Share the form via a link, letting anyone fill it out from any device.
Illustration
Export
Download, print, email, or move the form to your cloud storage.

Why pdfFiller is the best tool for your documents and forms

GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

End-to-end document management

From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.

Accessible from anywhere

pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.

Secure and compliant

pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.
Form preview

What is FDA 1571 IND

The Form FDA 1571 is a government document used by sponsors to submit an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration.

pdfFiller scores top ratings on review platforms

Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Show more Show less
Fill fillable FDA 1571 IND form: Try Risk Free
Rate free FDA 1571 IND form
4.5
satisfied
34 votes

Who needs FDA 1571 IND?

Explore how professionals across industries use pdfFiller.
Picture
FDA 1571 IND is needed by:
  • Clinical trial sponsors seeking drug approval
  • Pharmaceutical companies developing new drugs
  • Regulatory affairs professionals managing submissions
  • Authorized representatives acting on behalf of sponsors
  • Investigator institutions conducting clinical trials
  • Countersigners ensuring form accuracy and compliance

Comprehensive Guide to FDA 1571 IND

What is Form FDA 1571 - Investigational New Drug Application?

Form FDA 1571 serves as a crucial element in the submission of an Investigational New Drug Application (IND). It provides a structured format for sponsors to deliver essential details regarding new drugs and their associated clinical trials. The significance of this form lies in its role in ensuring compliance with regulatory requirements throughout the clinical trial process.
This form encapsulates key attributes that define the IND application, including information about the sponsor, drug characteristics, and trial methodologies. Understanding its importance helps in the meticulous preparation for clinical experiments.

Purpose and Benefits of Form FDA 1571

Form FDA 1571 plays an integral role in the drug approval process by serving as a communication tool between sponsors and the FDA. The clarity it provides allows FDA officials to assess investigational drugs and their intended use comprehensively.
Utilizing this form affords several benefits to sponsors involved in clinical trials. Clear communication of drug and trial details enhances understanding, which ultimately leads to a more efficient review process.

Eligibility Criteria for Form FDA 1571

Completion of Form FDA 1571 is mandatory for specific entities engaged in drug development. The individuals required to fill out this form typically include the sponsor and authorized representatives who oversee the application process.
Moreover, sponsors located outside the U.S. must consider additional factors when preparing the form, ensuring they meet all eligibility criteria set forth by the FDA.

How to Fill Out Form FDA 1571 Online (Step-by-Step)

Filling out Form FDA 1571 online can be efficiently accomplished through the following steps:
  • Access the form using pdfFiller to start the filling process.
  • Complete key fields, including sponsor information and drug specifics.
  • Review formatting and accuracy for all sections.
  • Ensure all necessary fields are filled to avoid submission delays.
  • Use the eSigning feature to authenticate the submission.
Each step is crucial for preventing common errors, enhancing the accuracy of submissions to the FDA.

Common Errors and How to Avoid Them

While filling out Form FDA 1571, users frequently encounter a variety of mistakes. Common errors include incomplete fields, incorrect sponsor details, and misinterpretation of required information.
To mitigate such issues, it is advisable to:
  • Thoroughly review all information before submission.
  • Utilize built-in validation features offered by online platforms such as pdfFiller.
Maintaining vigilance in the submission process is vital for ensuring regulatory compliance.

Submission Methods for Form FDA 1571

Form FDA 1571 can be submitted via various methods, each with its own guidelines. The submission can be either digital, making use of electronic platforms or traditional paper methods.
Understanding the requirements for signatures is essential. Key details include:
  • Digital submissions may require e-signatures for authentication.
  • Traditional methods necessitate hand signatures and possibly countersigning if the sponsor operates outside the U.S.

What Happens After You Submit Form FDA 1571?

Upon submission of Form FDA 1571, sponsors can expect a defined processing timeline and procedural steps. Sponsors should track their application status through the FDA's channels to stay informed about their submission.
The potential outcomes following submission include approval, additional information requests, or outright rejection, each of which will guide the next steps for the sponsor.

Security and Compliance for Form FDA 1571

When handling sensitive information contained within Form FDA 1571, employing secure methods is paramount. Utilizing platforms like pdfFiller ensures strict adherence to security standards, providing 256-bit encryption to protect documents.
Compliance with regulations such as HIPAA and GDPR is vital to safeguard clinical trial information, stressing the importance of data protection throughout the submission process.

Utilizing pdfFiller for Form FDA 1571

pdfFiller offers a comprehensive solution for managing Form FDA 1571, making it easier for users to fill out and submit their applications securely. Key features of pdfFiller include:
  • The ability to edit text and images seamlessly.
  • Options for eSigning, ensuring that legal standards are met during submission.
  • Tools for creating fillable forms, enhancing usability for sponsors.
Leveraging these features significantly enhances users' experiences when preparing Form FDA 1571.

Sample or Example of a Completed Form FDA 1571

To further assist users, a reference example of a completed Form FDA 1571 is available. This sample provides a clear illustration that can guide users as they fill out their own forms.
By referencing the sample, users can better understand how to accurately complete each section while avoiding common pitfalls encountered in the application process.
Last updated on Feb 26, 2015

How to fill out the FDA 1571 IND

  1. 1.
    Access the Form FDA 1571 on pdfFiller by visiting the official website and searching for the form in the templates section.
  2. 2.
    Once you locate the form, click on it to open it in the pdfFiller interface.
  3. 3.
    Review the form requirements carefully and gather all necessary information, including details about the drug and the clinical trial phases.
  4. 4.
    Navigate through the fields in the form using the mouse or keyboard to enter information. Utilize the fillable fields to input details like sponsor's name and address.
  5. 5.
    Ensure that accurate and complete information is entered for every required section to prevent delays in processing.
  6. 6.
    Once all information is filled out, review the form for any errors or omissions. Utilize pdfFiller’s editing tools to make adjustments as needed.
  7. 7.
    After thorough review, finalize the form by clicking the 'Save' button or choosing to download it in PDF format.
  8. 8.
    You can either submit the form electronically through the pdfFiller platform or print and mail it as per FDA submission guidelines.
Regular content decoration

FAQs

If you can't find what you're looking for, please contact us anytime!
The Form FDA 1571 can be submitted by any entity acting as a sponsor for a clinical investigation, including pharmaceutical companies, research institutions, and authorized representatives.
There is no specific deadline for submitting Form FDA 1571, but it must be completed before you initiate clinical trials. It's essential to check with the FDA for any specific timelines related to your IND submission.
After completing the form, you can submit it electronically through the pdfFiller platform. Alternatively, you can print it out and mail it to the FDA as per their submission procedures.
Along with Form FDA 1571, you may need to submit a protocol for the clinical trial, investigator’s brochure, and any other relevant documentation as required by the FDA.
Common mistakes include missing required signatures, omitting essential information about the drug or trials, and failing to review the completed form for errors before submission.
Processing times for Form FDA 1571 can vary. Generally, expect a response within 30 days, but complex submissions may take longer. Always check the FDA website for the latest information.
There are no fees directly associated with submitting Form FDA 1571. However, maintaining compliance with regulatory requirements may incur costs depending on your clinical trial’s needs.
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.